论文部分内容阅读
目的探讨小剂量低分子肝素钙在治疗慢性阻塞性肺病中的应用。方法 2008年2月至2011年2月收治的慢性阻塞性肺病患者131例,分为观察组66例和对照组65例。两组患者均给予低流量吸氧、抗感染、化痰止咳平喘、强心利尿扩血管等常规治疗,治疗组加用低分子肝素钙,并连续应用10 d。观察治疗前后临床症状的变化。结果治疗组总有效率为90.9%,明显高于对照组的64.6%,两组比较差异有统计学意义(P<0.05)。结论小剂量低分子肝素钙在治疗慢性阻塞性肺病疗效确切,值得临床推广应用。
Objective To investigate the application of low-dose low molecular weight heparin calcium in the treatment of chronic obstructive pulmonary disease. Methods 131 patients with chronic obstructive pulmonary disease admitted from February 2008 to February 2011 were divided into observation group (66 cases) and control group (65 cases). Two groups of patients were given low-flow oxygen, anti-infection, Huatanzhike asthma, cardiac diarrhea vasodilator and other conventional treatment, the treatment group with low molecular weight heparin, and continuous application of 10 d. Changes in clinical symptoms before and after treatment were observed. Results The total effective rate was 90.9% in the treatment group, which was significantly higher than that in the control group (64.6%). There was significant difference between the two groups (P <0.05). Conclusion Low dose of low molecular weight heparin in the treatment of chronic obstructive pulmonary disease is effective and worthy of clinical application.